long-read

Scaling Biology 002: Gevorg Grigoryan, Co-Founder and CTO at Generate:Biomedicines

On building a machine learning-powered generative biology platform with the ability to create new drugs on demand across a wide range of biologic…

Jan 26 •

and

Scaling Biology 001: Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals

On managing multidisciplinary teams, navigating the public markets, partnership mechanics with NVIDIA and Tempus and the future of spatial biology

Nov 20, 2023 •

Decoding Bio Snapshot 2023

a look into the next generation of bio companies

Jul 5, 2023 •

and

Decoding Biosecurity & Biodefense

Building a global immune system

Jun 13, 2023 •

,

,

,

, and

Morgan Cheatham

Going Zero to One in TechBio: Five Lessons from Waypoint Bio CEO and Co-Founder, Xinchen Wang

5 lessons on how to navigate challenges when building a bio platform from scratch

Jan 26, 2023 •

5 Bio Predictions for 2023

Business model innovation in techbio, the year of microglia, big tech backs up the truck in bio, enzyme combos drive expansion of genome editing…

Jan 4, 2023 •

,

,

,

, and

Morgan Cheatham

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts